GAO Ballot Package

This page is part of the FHIR Specification (v1.1.0: STU 3 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

This is a frozen snapshot of the FHIR specification created for the purpose of balloting the GAO implementation Guide. It includes draft changes that may be part of the future DSTU 2.1 release but further change is expected. Readers should focus solely on the GAO implementation content, and FHIR DSTU 2 for other purposes.

4.1.10 openEHR Archetype Profile

A set of extensions that define how the parts of the openEHR RiskOfAdverseReaction archetype that are not generaly encountered by implementers are represented

4.1.10.1 Content

Extensions:
openEHR-testObservations that confirm or refute :

Observations that confirm or refute the risk and/or the substance.

openEHR-locationBody site of manifestations :

The anatomical location / body site(s) where the symptoms manifested.

openEHR-exposureDateDate(/time) of first exposure to Substance :

Record of the date and/or time of the first exposure to the Substance for this Reaction Event.

openEHR-exposureDurationAmount of time individual was exposed to Substance :

The amount of time the individual was exposed to the Substance.

openEHR-exposureDescriptionText description about exposure to the Substance :

Text description about exposure to the Substance.

openEHR-administrationActual medication record, if known :

Link to an actual medication administration record with the full details of the administration, if a link is known.

openEHR-managementClinical Management Description :

Text description about the clinical management provided.

openEHR-careplanClinical Management Details :

Additional details about the clinical management provided for this Reaction Event.